Stocks' xChange unifies tokenized equity trading on Ethereum and Solana with real-world pricing and atomic onchain settlement.

Earnings call Profound Medical reported Q4 2025 revenue of CAD 6 million, up 43% year-over-year, with gross margin at 67% and a net loss of CAD 8.2 million. Management anticipates continued high ...

Good day, and welcome to Bilibili Fourth Quarter and Fiscal Year 2025 Financial Results and Business Update Conference Call. Today's conference is being recorded. At this time, I would like to turn ...

Was Amazon down today? Services resuming after customers couldn't check out on Thursday ...

Roboplasty Centre was already powered with three globally recognized robotic platforms — VELYS Robotic System, MAKO Robotic System, and CUVIS Robotic System. Despite this advanced infrastructure, the ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C ...

Escalation around Iran has already struck two pillars of the global economy: energy and transportation. Market charts may still show pauses and pullbacks out of sheer inertia. But in the physical ...

Aboitiz Equity Ventures Inc. reported that consolidated core net income remained unchanged at ₱25.5 billion for last year, as growth in its food and ...

GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H 2026 ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C mutationRezatap ...

This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...

GLP toxicology studies ongoing for CMP-002, with initiation of global Phase 1/2 clinical trial in SYNGAP1 patients expected as early as 2H 2026 Entered strategic collaboration with GSK to advance RNA- ...